(VCCEP) Tier 1 Pilot Submission for BENZENE - Tera
(VCCEP) Tier 1 Pilot Submission for BENZENE - Tera
(VCCEP) Tier 1 Pilot Submission for BENZENE - Tera
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
mice in the 300-ppm group had bilateral ovarian cysts after 91 days of exposure. Rats showed<br />
no evidence of damage to reproductive organs. In the National Toxicology Program (1986),<br />
benzene was evaluated <strong>for</strong> toxicity over 90 days and 2 years in F344 rats and B6C3F1 mice at<br />
oral gavage doses of 0 and 25–600 mg/kg/day, 5 days/week <strong>for</strong> 90 days; and 0, 5, 100, and<br />
200 mg/kg/day <strong>for</strong> male rats, or 0, 25, 50, and 100 mg/kg/day <strong>for</strong> female rats and all mice <strong>for</strong> 2<br />
years. No effects were seen in reproductive organs in either species treated <strong>for</strong> 90 days or in<br />
rats treated <strong>for</strong> 2 years. Ovarian lesions ranging from atrophy to neoplasia were observed in<br />
mice treated <strong>for</strong> 2 years, although no dose response was established, with a higher incidence of<br />
lesions occurring in the lowest dose (25 mg/kg/day).<br />
Spano et al. (1989) examined effects on mouse germ cells (C57Bl/Cne x C3H/Cne F1 male<br />
mice) using flow cytometry DNA content measurements on testicular monocellular suspensions,<br />
following a single oral dose by gavage of 0, 1, 2, 4, 6, and 7 mL/kg (approx. 0, 878, 1756, 3512,<br />
5268, and 6146 mg/kg) benzene. Treatment did not affect body or testes weights, but did alter<br />
the ratio of testicular cell types at the higher doses, suggesting acute toxicity to differentiating<br />
spermatogonia, with substantial to complete recovery by 70 days post-exposure. Mice exposed<br />
to benzene in intraperitoneal (ip) doses of 0.1–1.0 mL/kg (88–878 mg/kg) daily <strong>for</strong> 5 days<br />
exhibited statistically significant dose-related increases in sperm-head abnormalities at<br />
0.4 mL/kg and higher, with peak effect at 0.6 mL/kg (Topham, 1980). Benzene also caused<br />
dose-related increases in chromosome aberrations in sperm of mice following single oral doses<br />
of 0.25, 0.5, or 1.0 mL/kg benzene (Ciranni et al., 1991)<br />
The ability of benzene to affect female reproductive fertility appears limited. The Kuna et al.<br />
study suggests 300 ppm to be a NOAEL when exposures are limited to 6 hours/day. Effects on<br />
male fertility have been assessed only indirectly. Male rats appear to be relatively resistant to<br />
adverse effects of benzene exposure on fertility, as measured by insemination of females and<br />
effects on reproductive organs. Male mice appear to be more sensitive than male rats in terms<br />
of effects on the testes, and CD-1 mice appear to be more sensitive than B6C3F1 mice,<br />
although differences in exposure routes complicate this comparison. There are no studies<br />
available where both parental animals have been exposed to benzene prior to mating.<br />
6.2.3.2 Developmental Toxicity<br />
Possible toxic effects of benzene during the embryonic and fetal periods are included under the<br />
heading of developmental toxicity. Transplacental genotoxicity is discussed in Section 6.2.2.3<br />
of the genotoxicity section. Data are available on developmental effects of benzene during<br />
embryogenesis in rats, mice, and rabbits, by the inhalation and oral routes - see Table 6.3, from<br />
EPA IRIS (U.S. EPA 1998b). Studies describing exposures during both the embryonic and fetal<br />
period, with subsequent examination of the fetuses (as would be done under current testing<br />
guidelines), are not available.<br />
Inhalation<br />
Kuna and Kapp (1981) exposed pregnant Sprague Dawley rats to benzene concentrations of 0,<br />
10, 50, and 500 ppm (0, 32, 160, and 1600 mg/m 3 ), 7 hours/day on GD6–15, with maternal<br />
sacrifice at GD20. Hematological evaluations per<strong>for</strong>med on GD 5 and 20 included red blood<br />
cells (RBC), white blood cells (WBC), and differential counts. There were no maternal deaths,<br />
illness, or hematologic changes. During GD5–15, decreased maternal body weight gains were<br />
observed in the 50- and 500-ppm exposed groups, and increased body-weight gains were<br />
observed in the 10- and 500-ppm groups during GD15–20. No differences from controls were<br />
observed in the number of implantation sites per number of corpora lutea; incidences of<br />
Benzene <strong>VCCEP</strong> <strong>Submission</strong><br />
March 2006<br />
72